Biotech Investing

BioXcel Therapeutics to Expand BXCL701 Study

Biotech Investing

Dare Biosciences and FDA Align on Phase 2b Study Design of Sildenafil

Biotech Investing

MacroGenics Presents Results from SOPHIA Study

Biotech Investing

Algernon Pharmaceuticals to Present at 12th Annual LD Micro Main Event Conference on Wednesday December 11, 2019

Pharmaceutical Investing

Mustang Bio Announces Additional Clinical Data on MB-107

Biotech Investing

Abeona Therapeutics to Initiate Phase 3 Clinical Trial of B-101

Biotech Investing

Ocugen Completes 50 Percent Enrollment in Phase 3 Clinical Trial

Biotech Investing

Achillion Reports Positive Data from Phase 2 Study of Danicopan

Biotech Investing

Aprea Therapeutics Presents Data from Phase 1b/2 Clinical Trial of APR-246

Biotech Investing

NanoSphere Provides Update on United States Operations

Cannabis Investing News

Algernon Pharmaceuticals Selects NP-120 (Ifenprodil) for its Lead Phase 2 Trial for Idiopathic Pulmonary Fibrosis and Chronic Cough

Pharmaceutical Investing

5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent

Biotech Investing

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES